ECS Botanics Holdings Ltd
ECS Botanics Holdings Ltd (ECS.AX) Financial Performance & Income Statement Overview
Explore the financials of ECS Botanics Holdings Ltd (ECS.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
ECS Botanics Holdings Ltd (ECS.AX) Income Statement & Financial Overview
View the income breakdown for ECS Botanics Holdings Ltd ECS.AX across both annual and quarterly reports.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $9.73M | $8.75M | $11.28M | $8.47M |
| Cost of Revenue | $7.36M | $5.35M | $12.88M | $8.59M |
| Gross Profit | $2.38M | $3.40M | -$1.59M | -$122507.00 |
| Gross Profit Ratio | $0.24 | $0.39 | -$0.14 | -$0.01 |
| R&D Expenses | $0.00 | $42126.00 | $52126.00 | $0.00 |
| SG&A Expenses | $4.31M | $360277.00 | $659536.00 | $279249.00 |
| Operating Expenses | $4.31M | $2.91M | $711662.00 | $455439.00 |
| Total Costs & Expenses | $11.66M | $8.26M | $13.59M | $9.05M |
| Interest Income | $5111.00 | $20292.00 | $15063.00 | $18663.00 |
| Interest Expense | $79406.00 | $43209.00 | $18562.00 | $0.00 |
| Depreciation & Amortization | $709256.00 | $665397.00 | $662695.00 | $640910.00 |
| EBITDA | -$1.20M | $1.26M | $1.91M | $1.90M |
| EBITDA Ratio | -$0.12 | $0.14 | $0.17 | $0.007 |
| Operating Income | -$1.93M | $488317.00 | $866081.00 | -$577950.00 |
| Operating Income Ratio | -$0.20 | $0.06 | $0.08 | -$0.07 |
| Other Income/Expenses (Net) | -$53069.00 | $108596.00 | $382182.00 | $875062.00 |
| Income Before Tax | -$1.98M | $596913.00 | $1.25M | $1.86M |
| Income Before Tax Ratio | -$0.20 | $0.07 | $0.11 | $0.22 |
| Income Tax Expense | $0.00 | -$70388.00 | $5.00 | $262991.00 |
| Net Income | -$1.98M | $667301.00 | $1.25M | $1.59M |
| Net Income Ratio | -$0.20 | $0.08 | $0.11 | $0.19 |
| EPS | -$0.002 | $0.001 | $0.001 | $0.001 |
| Diluted EPS | -$0.002 | $0.001 | $0.001 | $0.001 |
| Weighted Avg Shares Outstanding | $1.29B | $1.14B | $1.11B | $1.11B |
| Weighted Avg Shares Outstanding (Diluted) | $1.29B | $1.14B | $1.11B | $1.11B |
Over the last four quarters, ECS Botanics Holdings Ltd's revenue moved from $8.47M in Q4 2023 to $9.73M in Q2 2025. Operating income in Q2 2025 was -$1.93M, with a strong operating margin of -20%. Despite fluctuations in R&D and SG&A expenses, EBITDA for ECS Botanics Holdings Ltd remained robust at -$1.20M, reflecting operational efficiency. Net income dropped to -$1.98M, with an EPS of -$0.002. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan